Brief: European Medicines Agency Approves Nanexa's Clinical Trial Application For Phase I Study With NEX-22
15/05/2024 13:23
May 15 (Reuters) - Nanexa AB NANEXA.ST :
* EUROPEAN MEDICINES AGENCY HAS APPROVED COMPANY'S CLINICAL
TRIAL
APPLICATION FOR PHASE I STUDY WITH NEX-22
Source text for Eikon: ID:nMFN9125pM
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))